Houlihan Lokey Advises OPEN Health

Houlihan Lokey is pleased to announce that OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry, a portfolio company of Amulet Capital Partners, LP (Amulet), has been acquired by Astorg. The transaction closed on July 13, 2022.

Established in 2011 and headquartered in London, OPEN Health is a key partner to its customers in helping them develop strategies for evidence generation and data communication by leveraging their extensive scientific knowledge and relentless focus on quality. Together, this approach consistently delivers best-in-class scientific communications, HEOR, and market access services to an ever-increasing audience.

OPEN Health has more than 1,000 employees in 15 locations and six countries, across North America, Europe, and Asia. OPEN Health serves over 170 life sciences customers, including 48 of the top 50 pharmaceutical companies. OPEN Health’s existing management team, led by CEO Rob Barker, will continue to lead the organization, building on a strong track record of organic growth and strategic acquisitions.

Astorg is a European private equity firm with over €17 billion of assets under management. Astorg works with entrepreneurs and management teams to acquire market-leading global companies headquartered in Europe or the U.S., providing them with the strategic guidance, governance, and capital they need to achieve their growth plans.

Amulet is a middle-market private equity investment firm based in Greenwich, Connecticut, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies.

Houlihan Lokey served as exclusive financial advisor to OPEN Health and Amulet. This deal highlights Houlihan Lokey’s leading experience in the pharma services space and represents the firm’s 14th transaction in this sector since 2019.